TOSTI GUERRA, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.174
EU - Europa 751
AS - Asia 156
AF - Africa 2
Totale 2.083
Nazione #
US - Stati Uniti d'America 1.169
PL - Polonia 266
IE - Irlanda 119
SE - Svezia 99
IT - Italia 69
UA - Ucraina 54
CN - Cina 53
HK - Hong Kong 52
RU - Federazione Russa 37
DE - Germania 36
SG - Singapore 25
GB - Regno Unito 23
FI - Finlandia 20
BE - Belgio 10
TR - Turchia 9
JO - Giordania 8
CH - Svizzera 6
FR - Francia 6
CA - Canada 5
VN - Vietnam 4
IN - India 3
ES - Italia 2
NL - Olanda 2
SC - Seychelles 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
KR - Corea 1
Totale 2.083
Città #
Warsaw 266
Fairfield 152
Chandler 143
Dublin 119
Ann Arbor 80
Woodbridge 79
Jacksonville 78
Ashburn 70
Seattle 69
Wilmington 69
Cambridge 68
Houston 53
Hong Kong 28
Boardman 25
Buffalo 23
Princeton 23
Boston 20
Lawrence 20
Beijing 19
Singapore 19
Altamura 18
Shanghai 15
Florence 14
New York 12
Medford 11
Brussels 10
Izmir 9
San Diego 9
Bern 6
Bremen 5
Guangzhou 5
Norwalk 5
Prato 5
Frankfurt Am Main 4
Kent 4
Las Vegas 4
Verona 3
Andover 2
Auburn Hills 2
Barcelona 2
Bologna 2
Dong Ket 2
London 2
Los Angeles 2
Meppel 2
Milan 2
Phoenix 2
Toronto 2
Washington 2
Bari 1
Bolzano 1
Brno 1
Chiswick 1
Civitanova Marche 1
Comeana 1
Dallas 1
Dearborn 1
Detroit 1
Helsinki 1
Hillsboro 1
Iowa City 1
Jinhua 1
Kollam 1
Laurel 1
Montréal 1
Moscow 1
Munich 1
North Bergen 1
Ottawa 1
Pune 1
Rome 1
Salerno 1
San Lazzaro Di Savena 1
Segrate 1
Seoul 1
Shangdi 1
Sofia 1
St. Catharines 1
Stockholm 1
Suri 1
Tappahannock 1
Totale 1.618
Nome #
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 222
Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 220
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 113
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 107
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 100
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 99
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 97
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 92
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 91
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 87
Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure. 83
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 83
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 81
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 74
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 72
Long-Term Vaginal Danazol Treatment in Fertile Age Women with Adenomyosis 71
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 68
Hormonal therapy for endometriosis: from molecular research to bedside 64
Current and Future Medical Treatment of Adenomyosis 62
Endothelin-1 is overexpressed in cirrhotic liver and exerts multiple effects on activated human hepatic stellate cells. 58
Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: Association with symptoms 57
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 48
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 39
Totale 2.088
Categoria #
all - tutte 5.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020418 0 37 9 44 51 55 47 57 40 32 41 5
2020/2021252 18 18 29 29 12 25 8 25 15 37 15 21
2021/2022195 6 13 14 9 7 9 6 10 6 6 50 59
2022/2023505 38 99 22 52 45 82 58 36 52 2 11 8
2023/2024196 10 21 27 11 8 42 20 34 10 3 6 4
2024/202562 42 20 0 0 0 0 0 0 0 0 0 0
Totale 2.088